There are globally over 300 million people with high intra-ocular pressure (IOP), which can lead to glaucoma and blindness. Glaucoma is mostly asymptomatic and disease progress can go unnoticed because the build up of pressure is gradual and painless. People often do not detect a change in vision until substantial loss of sight has occurred. There is a need for novel solutions in glaucoma screening, measuring and monitoring which are essential to diagnosis, treatment and follow-up. Our next generation solution for glaucoma is under development.